Sectivia

Boston ScientificBSX

NYSE · USA · Segment 7 of 8 in the Medicine, pharma & life science value chain: Medtech & devices

American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.

Medtech & devices: Medical equipment and devices — from surgery and cardiology to robotics.

Key metrics

Market cap
$66.9B
Price
$44.44
Today
−1.2%
Return YTD
−52.8%
Return 1Y
−56.3%
P/E
18.8
P/S
3.2
P/B
2.6

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

MedtechCardiologyElectrophysiology

In the value chain

Products & services

  • Electrophysiology (Farapulse)
  • Structural heart
  • Endoscopy & urology

Competitors

Risks

  • Competition in electrophysiology
  • Acquisition integration

Same segment: Medtech & devices

See where Boston Scientific sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →